Klinische Wochenschrift

, Volume 68, Issue 9, pp 454–459 | Cite as

Consequences of current lipid guidelines for the Federal Republic of Germany

  • L. Kohlmeier
  • H. Hoffmeister


According to the results of the first nationally representative population study in the Federal Republic of Germany (FRG) conducted in 1984–1986, a vast majority of the population have elevated cholesterol levels and undesirable low density lipoprotein (LDL) cholesterol levels. This problem increases with age in two dimensions, more individuals become hyperlipemic and those who were hyperlipemic develop more extreme pathologic values. Preliminary analyses suggest that the national profile in the FRG is worse than that of the USA. Based on the current recommendations of the national cholesterol education program of the USA, 23 million adults in the FRG should be receiving dietary advice for elevated lipid levels and 18 million persons should be in regular treatment programs. Consequently, implementation of such a national strategy and program would require the assembly and training of an adequate professional body of physicians and support staff in the diagnosis and treatment of hyperlipidemias.

Key words

Cholesterol LDL cholesterol National survey Costs 



high density lipoprotein cholesterol


low density lipoprotein cholesterol


cardiovascular disease


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Blackburn H (1988) The Evaluation of mass atherosclerotic disease: the rationale for primary prevention. Ann Clin Res 20:4–9Google Scholar
  2. 2.
    Block L, Banspach SW, Gans K, Harris C, Lasater TM, Lefebvre C, Carleton RA (1988) Impact of public education and continuing medical education on physician attitudes and behavior concerning cholesterol. Am J Prev Med 4:255–260Google Scholar
  3. 3.
    Delong DM, Delong ER, Wood PD, Lippel K, Rifkind BM (1986) A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The lipid Research Clinics Prevalence Study. JAMA 256:2372–2377Google Scholar
  4. 4.
    Deutsche Herz-Kreislauf-Präventionsstudie (1989) Vorsorge gegen Herz-Kreislauf-Krankheiten: Beiträge der Forschung. Programmreport 1989, Design; Methoden, Ergebnisse zur Studienmitte. Der Bundesminister für Forschung Technologie, BonnGoogle Scholar
  5. 5.
    European Atherosclerosis Society (1988) Strategies for the prevention of coronary heart disease; a policy statement for the European Atherosclerosis Society. Eur Heart J 8:77–88Google Scholar
  6. 6.
    Expert Panel (1988) Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 148:36–69Google Scholar
  7. 7.
    Friedewald WT, Levy RI, Frederickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502Google Scholar
  8. 8.
    GCP Study Group (1988) The German Cardiovascular Prevention Study (GCP): design and methods. Eur Heart J 10:1058–1066Google Scholar
  9. 9.
    Henke K-D, Behrens C, Arab L, Schlierf G (1986) Die Kosten ernährungsbedingter Krankheiten. Band 179 der Schriftenreihe des Bundesministers für Jugend, Familie, Frauen und Gesundheit. Kohlhammer, StuttgartGoogle Scholar
  10. 10.
    Hoffmeister H, Junge B (1988) Mortalität an ernährungsbedingten Krankheiten. Ernährungsbericht 1988. Deutsche Gesellschaft für Ernährung, Frankfurt am MainGoogle Scholar
  11. 11.
    Hoffmeister H, Hoeltz J, Schön D, Schröder E, Güther B (1988) Nationaler Untersuchungs-Survey und regionale Untersuchungs-Surveys der DHP Band I DHP Forum, Deutsche Herz-Kreislauf-PräventionsstudieGoogle Scholar
  12. 12.
    Hoffmeister H, Stolzenberg H, Schön D, Thefeld W, Hoeltz J, Schröder E (1988) Nationaler Untersuchungs-Survey und regionale Untersuchungs-Surveys der DHP Band II DHP Forum, Deutsche Herz-Kreislauf-PräventionsstudieGoogle Scholar
  13. 13.
    Junge B (1985) Decline in mortality in Japan, USA and the Federal Republic of Germany — the contribution of the specific causes of death. Klin Wochenschr 63:793–801Google Scholar
  14. 14.
    Laemmle P, Unger L, McCray C, Geisler M, Chalin M, Hardy RI, Glueck CJ (1988) Know your cholesterol: population screening. J Lab Clin Med 112:567–574Google Scholar
  15. 15.
    Leaf A (1989) Management of hypercholesterilemia. Are preventive interventions advisable? N Engl J Med 321:680–684Google Scholar
  16. 16.
    National Center for Health Statistics (1986) Total serum cholesterol levels of adults 20–74 years of age: United States. 1976–1980. Vital and health statistics, Ser II, no 236. Department of Health and Human Services publication (PHS) 86-1686, Government Printing Office, Washington, D.C.Google Scholar
  17. 17.
    Rästram L, Luepker RV, Pirie PL (1988) Effects of screening and referral on follow-up and treatment of high blood cholesterol levels. Am J Prev Med 4:244–248Google Scholar
  18. 18.
    Schucker B, Wittes JT, Cutler JA, Bailey K, Mackintosh DR, Gordon DJ, Haines CM, Mattson ME, Goor RS, Rifkind BM (1987) Change in physician perspective on cholesterol and heart disease. JAMA 258:3521–3526Google Scholar
  19. 19.
    Statistisches Bundesamt (1988) Statistisches Jahrbuch 1988 für die Bundesrepublik Deutschland. Kohlhammer, StuttgartGoogle Scholar
  20. 20.
    WHO Expert Committee (1986) Community prevention and control of cardiovascular diseases. Technical report series 732. WHO, GenevaGoogle Scholar
  21. 21.
    Wilson PWF, Christiansen JC, Anderson KM, Kannel WB (1989) Impact of national guidelines for cholesterol risk factor screening. JAMA 262:41–44Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • L. Kohlmeier
    • 1
  • H. Hoffmeister
    • 1
  1. 1.Institut für Sozialmedizin und Epidemiologie des BundesgesundheitsamtesBerlin

Personalised recommendations